NICE approves combination therapy for hepatitis C
Combination drugs for hepatitis C have been recommended by the National Institute for Clinical Excellence. NICE said that patients suffering from moderate or severe hepatitis C should be given a combination of the drugs interferon alpha and ribavirin. Until June 1999, interferon alpha was the only licensed treatment for chronic ...
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here